Consensus Aarti Drugs Limited NSE India S.E.

Equities

AARTIDRUGS

INE767A01016

Market Closed - NSE India S.E. Other stock markets 07:40:29 2024-05-08 am EDT			5-day change	1st Jan Change
474.1 ^INR	-0.41%		-6.04%	-3.09%

May. 06	Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024
May. 03	Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Aarti Drugs Limited

Price target over the last 5 years

History of analyst recommendation changes

1d8365c18f31915c78a16ff3537.WhQ4aQaWIaDxb1Xe1FF_QlSusYxByxnUZ9w8fZLtfaU.d11zATX9Te6lAR6GjBYaMxjN_MAYm0vsVLpEReCOMegMdnIDTPxRkIcqGA~db83a5cf2ded0eb2c1f492c1007a19e9

Analyst Recommendations on Aarti Drugs Limited

Aarti Drugs : Crisil Affirms Ratings on Aarti Drug's Bank Loan; Outlook Stable	21-05-03	MT
Aarti Drugs : ICRA Affirms Rating on Aarti Drugs' Term Loan; Outlook Stable	21-04-15	MT
Aarti Drugs : ICRA Givers AA- Rating on Aarti Drugs' Term Loan; Outlook Stable	21-03-28	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

474.4 INR

Average target price

542 INR

Spread / Average Target

+14.26%

High Price Target

542 INR

Spread / Highest target

+14.26%

Low Price Target

542 INR

Spread / Lowest Target

+14.26%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar